National Planning Corporation’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

National Planning Corporation’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3,342	Closed	-$289K	–	628
2017 Q3	$289K	Buy	3,342 +632	+23%	+$50.7K	0.02%	539
2017 Q2	$211K	Buy	+2,710	New	+$192K	0.02%	660
2016 Q1	–	Sell	-16,338	Closed	-$792K	–	738
2015 Q4	$792K	Buy	16,338 +12,737	+354%	+$869K	0.06%	295
2015 Q3	$259K	Sell	3,601 -13,940	-79%	-$1.1M	0.02%	495
2015 Q2	$1.37M	Buy	17,541 +11,595	+195%	+$902K	0.12%	171
2015 Q1	$416K	Buy	5,946 +2,586	+77%	+$181K	0.04%	407
2014 Q4	$215K	Sell	3,360 -555	-14%	-$31.6K	0.02%	641
2014 Q3	$207K	Buy	+3,915	New	+$200K	0.02%	656
2014 Q2	–	Sell	-4,440	Closed	-$214K	–	774
2014 Q1	$214K	Buy	+4,440	New	+$227K	0.02%	628

Other funds holding XBI

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

National Planning Corporation's XBI Position: Q4 2017 in Review

National Planning Corporation sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2017, closing a stake of 3,342 shares — an estimated $289K sold.

National Planning Corporation first reported a position in XBI in Q1 2014 and held it in 9 quarters. The position peaked at $1.37M in Q2 2015. 397 funds tracked by Wall St. Rank hold XBI as of Q4 2017.

National Planning Corporation reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2017 after selling out during the quarter.
National Planning Corporation sold 3,342 State Street SPDR S&P Biotech ETF shares in Q4 2017, an estimated $289K.
National Planning Corporation first reported a position in State Street SPDR S&P Biotech ETF in Q1 2014 and held it in 9 quarters.
National Planning Corporation's State Street SPDR S&P Biotech ETF position peaked at $1.37M in Q2 2015.
397 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2017.

Based on National Planning Corporation's 13F filing for Q4 2017, filed 14 Feb 2018.